New Orleans, LA - Cardiac resynchronization therapy (CRT) may reverse ventricular remodeling and improve LVEF in subgroups of HF patients for whom there are few prospective data supporting a benefit, ...
Camzyos is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the source of obstructive HCM PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results